Goldman Sachs Group Inc Sc Pharmaceuticals Inc. Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 76,880 shares of SCPH stock, worth $435,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,880

Previous 101,888 24.54%

Holding current value

$435,909

Previous $388,000 12.11%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.86 - $5.84 $96,530 - $146,046	-25,008 Reduced 24.54%	76,880 $435,000
Q2 2025 Aug 14, 2025	SELL	$2.02 - $4.27 $38,398 - $81,168	-19,009 Reduced 15.72%	101,888 $388,000
Q1 2025 May 09, 2025	SELL	$2.63 - $3.68 $758,920 - $1.06 Million	-288,563 Reduced 70.47%	120,897 $317,000
Q4 2024 Feb 11, 2025	BUY	$3.14 - $4.53 $1.05 Million - $1.52 Million	334,691 Added 447.63%	409,460 $1.45 Million
Q3 2024 Nov 14, 2024	BUY	$4.12 - $5.51 $166,027 - $222,041	40,298 Added 116.9%	74,769 $340,000

Q2 2024 Aug 13, 2024	BUY	$3.51 - $5.21 $21,488 - $31,895	6,122 Added 21.6%	34,471 $149,000
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $81,876 - $107,652	-16,847 Reduced 37.28%	28,349 $142,000
Q4 2023 Feb 13, 2024	BUY	$4.7 - $6.63 $114,219 - $161,122	24,302 Added 116.31%	45,196 $283,000
Q3 2023 May 14, 2024	SELL	$7.0 - $9.82 $170,114 - $238,645	-24,302 Reduced 53.77%	20,894 $148,000
Q3 2023 Nov 14, 2023	BUY	$7.0 - $9.82 $146,258 - $205,179	20,894 New	20,894 $148,000
Q1 2023 May 14, 2024	BUY	$5.59 - $9.47 $462,723 - $783,898	82,777 Added 314.08%	109,132 $989,000
Q1 2023 May 11, 2023	BUY	$5.59 - $9.47 $462,723 - $783,898	82,777 Added 314.08%	109,132 $989,000
Q4 2022 May 14, 2024	SELL	$4.02 - $7.53 $75,740 - $141,872	-18,841 Reduced 41.69%	26,355 $188,000
Q4 2022 Feb 13, 2023	BUY	$4.02 - $7.53 $105,947 - $198,453	26,355 New	26,355 $188,000

Others Institutions Holding SCPH

# of Institutions

117

Shares Held

38.3M

Call Options Held

835K

Put Options Held

173K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $155M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Sc Pharmaceuticals Inc. Transaction History